help button home button Am J Pathol Epitomics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2009.080765 on April 23, 2009

Published online before print April 23, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
ajpath.2009.080765v1
174/6/2129    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomay, A. A.
Right arrow Articles by Albina, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomay, A. A.
Right arrow Articles by Albina, J. E.
(American Journal of Pathology. 2009;174:2129-2136.)
© 2009 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2009.080765

Disruption of Interleukin-1 Signaling Improves the Quality of Wound Healing

Alan A. Thomay*, Jean M. Daley*, Edmond Sabo{dagger}, Patrick J. Worth*, Leslie J. Shelton{ddagger}, Mark W. Harty*, Jonathan S. Reichner* and Jorge E. Albina*

From the Departments of Surgery,* and Pathology,{dagger} Rhode Island Hospital and The Alpert Medical School, and the Department of Physics,{ddagger} Division of Engineering, Brown University, Providence, Rhode Island

In this study, we investigated the role of interleukin (IL)-1 signaling in wound healing. IL-1 receptor type I (IL-1R) knockout (KO) mice showed reduced fibrosis in both cutaneous and deep tissue wounds, which was accompanied by a reduction in inflammatory cellular infiltration in cutaneous but not in deep tissue wounds. There were no differences in either total collagenolytic activity or in the expression of selected matrix metalloproteinases or tissue inhibitors of metalloproteinases between the wound fluids from wild-type or IL-1R KO mice. However, wound fluids from IL-1R KO mice contained lower levels of IL-6 compared with wild-type controls. In addition, the infusion of IL-6 into wounds in IL-1R KO mice did not increase fibrosis. Skin wounds in IL-1R KO animals had lower levels of collagen and improved restoration of normal skin architecture compared with skin wounds in wild-type mice. However, neither the tensile strength of incisional skin wounds nor the rate of closure of excisional wounds differed between IL-1R KO and wild-type animals. The reduced fibrotic response in wounds from IL-1R KO mice could be reproduced by the administration of an IL-1R antagonist. These findings suggest that pharmacological interference with IL-1 signaling could have therapeutic value in the prevention of hypertrophic scarring and in the treatment of fibrotic diseases.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
J. M. Daley, S. K. Brancato, A. A. Thomay, J. S. Reichner, and J. E. Albina
The phenotype of murine wound macrophages
J. Leukoc. Biol., January 1, 2010; 87(1): 59 - 67.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society for Investigative Pathology.